DCF — CLEARVISTA HEALTH & WELNESS
Enterprise Value: $-19.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-19.9M
Enterprise Value
$-6.2M
PV of Cash Flows
$-13.7M
PV of Terminal Value
$-22.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $9.8M | $-1.3M | -13.0% | $-1.7M | $-1.5M |
| Year 2 | $10.1M | $-1.2M | -12.0% | $-1.7M | $-1.4M |
| Year 3 | $10.4M | $-1.2M | -11.0% | $-1.6M | $-1.2M |
| Year 4 | $10.8M | $-1.1M | -11.0% | $-1.6M | $-1.1M |
| Year 5 | $11.1M | $-1.1M | -10.0% | $-1.6M | $-1.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-19.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$9.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.13554933755786897
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5